Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-10T08:21:22.921Z Has data issue: false hasContentIssue false
  • English
  • Français

Patient satisfaction with psychotropic drugs: sensitivity to change and relationship to clinical status, quality-of-life, compliance and effectiveness of treatment. Results from a nation-wide 6-month prospective study

Published online by Cambridge University Press:  16 April 2020

Isabelle Gasquet ,
Stéphanie Tcherny-Lessenot ,
Jean-Pierre Lépine  and
Bruno Falissard
Isabelle Gasquet*
Affiliation:
National Institute of Health and Medical Research-U669 (Paris–Sud Innovation Group in Adolescent Mental Health Methodology), Maison des Adolescents, Cochin Hospital, Paris, France Direction de la Politique Médicale, Assistance Publique-Hôpitaux de Paris, Paris, France
Stéphanie Tcherny-Lessenot
Affiliation:
Lilly France, Suresnes, France
Jean-Pierre Lépine
Affiliation:
Psychiatry Department, Fernand Widal Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
Bruno Falissard
Affiliation:
National Institute of Health and Medical Research-U669 (Paris–Sud Innovation Group in Adolescent Mental Health Methodology), Maison des Adolescents, Cochin Hospital, Paris, France
*
*Corresponding author. E-mail address: isabelle.gasquet@sap.aphp.fr (I. Gasquet).
Get access

Abstract

Objective

To see if patient satisfaction with psychotropics (PSP) could be used as a patient-oriented outcome variable in the evaluation of PSP drugs in clinical epidemiological studies, relationships between PSP, clinical status, QoL, compliance and the type of antipsychotic were analyzed. Elements of validation of PSP were also assessed.

Method

In a 6-month prospective study, 933 schizophrenic outpatients with initiation or change to their antipsychotic treatment were enrolled. Psychiatrists completed five CGI-SCH scales (positive, negative, cognitive, depressive and global), hospitalization, compliance, and prescription variables. Patients completed PSP, EuroQoL scales, sexual function and compliance variables.

Results

A satisfactory structural equation model was obtained showing significant relationships PSP/compliance (coef. = 0.16), QoL/PSP (coef. = 0.37), clinical status/QoL (coef. = 0.61), clinical status/compliance (coef. = 0.09). Patients receiving olanzapine were more satisfied than patients receiving other atypicals (coef. =0 12) and had better clinical status than patients treated with typicals (coef. = 0.08). Evolution of PSP was related to clinical status, QoL, and continuation of treatment (all P < 001). Sensitivity to change of PSP was moderate (effect size = 0.2).

Conclusion

PSP produced consistent results in relation to validated outcome variables. However, a single-item measure was not sufficiently sensitive to change. Multi-item questionnaires evaluating different dimensions are needed.

Keywords

Patient satisfactionSchizophreniaPsychometricsQuality-of-lifePatient complianceAntipsychotic agents
Type
Original article
Information
European Psychiatry , Volume 21 , Issue 8 , December 2006 , pp. 531 - 538
Copyright
Copyright © Elsevier Masson SAS 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albrecht, G., Hoogstraten, J.Satisfaction as a determinant of compliance Community Dent. Oral Epidemiol. 1998; 26:139–146.CrossRefGoogle ScholarPubMed
Atkinson, M., Sinha, A., Hass, S., Colman, S., Kumar, R., Brod, M.et al.Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease Health Qual. Life Outcomes 2004; 2:12.CrossRefGoogle Scholar
Awad, A., Voruganti, L.Intervention research in psychosis: issues related to the assessment of quality of life Schiz. Bull. 2000; 26:557–564.CrossRefGoogle ScholarPubMed
Awad, A.G.Subjective response to neuroleptics in schizophrenia Schizophr. Bull. 1993; 19:609–618.CrossRefGoogle Scholar
Awad, A.G., Voruganti, L.N.Quality of life and new antipsychotics in schizophrenia. Are patients better off? Int. J. Soc. Psychiatry 1999; 45:268–275.CrossRefGoogle ScholarPubMed
Babiker, I.E., Thorne, P.Do psychiatric patients know what is good for them? J. R. Soc. Med. 1993; 86:28–30.Google Scholar
Baker, L., Zucker, P.J., Gross, M.J.Using client satisfaction surveys to evaluate and improve services in locked and unlocked adult inpatient facilities J. Behav. Health Serv. Res. 1998; 25:51–63.CrossRefGoogle ScholarPubMed
Barker, D.A., Shergill, S.S., Higginson, I., Orrell, M.W.Patients’ views towards care received from psychiatrists Br. J. Psychiatry 1996; 168:641–646.CrossRefGoogle ScholarPubMed
Bosnjak, S., Radulovic, S., Neskovic-Konstantinovic, Z., Mitrovic, L.Patient statement of satisfaction with antiemetic treatment is related to quality of life Am. J. Clin. Oncol. 2000; 23:575–578.CrossRefGoogle ScholarPubMed
Bradley, C., Lewis, K.S.Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes Diabet. Med. 1990; 7:445–451.CrossRefGoogle ScholarPubMed
Bradley, C.P.Uncomfortable prescribing decisions: a critical incident study BMJ 1992; 304:294–296.CrossRefGoogle ScholarPubMed
Bredart, A., Razavi, D., Robertson, C., Brignone, S., Fonzo, D., Petit, J.Y.et al.Timing of patient satisfaction assessment: effect on questionnaire acceptability, completeness of data, reliability and variability of scores Patient Educ. Couns. 2002; 46:131–136.CrossRefGoogle ScholarPubMed
Britten, N.Patients’ demands for prescriptions in primary care BMJ 1995; 310:1084–1085.CrossRefGoogle ScholarPubMed
Britten, N., Ukoumunne, O.The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey BMJ 1997; 315:1506–1510.CrossRefGoogle ScholarPubMed
Brody, D.S., Miller, S.M., Lerman, C.E., Smith, D.G., Caputo, G.C.Patient perception of involvement in medical care: relationship to illness attitudes and outcomes J. Gen. Intern. Med. 1989; 4:506–511.CrossRefGoogle ScholarPubMed
Ceballos Hernansanz, M.A., Sanchez Roy, R., Cano Orgaz, A., Lopez-Gil, A.Migraine treatment patterns and patient satisfaction with prior therapy: A substudy of a multicenter trial of rizatriptan effectiveness Clin. Ther. 2003; 25:2053–2069.CrossRefGoogle ScholarPubMed
Clotet, B., Carmena, J., Pulido, F., Luque, I., Rodriguez-Alcantara, F.Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients HIV Clin. Trials 2004; 5:33–39.Google ScholarPubMed
Cramer, J., Rosenheck, R., Xu, W., Thomas, J., Henderson, W., Charney, D.Quality of life in schizophrenia: a comparison of instruments Schiz Bull 2000; 26:659–666.CrossRefGoogle ScholarPubMed
Day, J.C., Bentall, R.P., Roberts, C., Randall, F., Rogers, A., Cattell, D.et al.Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals Arch. Gen. Psychiatry 2005; 62:717–724.CrossRefGoogle ScholarPubMed
Day, J.C., Bentall, R.P., Warner, S.Schizophrenic patients’ experiences of neuroleptic medication: a Q-methodological investigation Acta Psychiatr. Scand. 1996; 93:397–402.CrossRefGoogle ScholarPubMed
de Haan, L., Weisfelt, M., Dingemans, P.M., Linszen, D.H., Wouters, L.Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale Psychopharmacology (Berl.) 2002; 162:24–28.CrossRefGoogle ScholarPubMed
Deyo, R.A., Inui, T.S.Dropouts and broken appointments. A literature review and agenda for future research Med. Care 1980; 18:1146–1157.CrossRefGoogle ScholarPubMed
Diamond, R.Drugs and the quality of life: the patient’s point of view J. Clin. Psychiatry 1985; 46:29–35.Google ScholarPubMed
Donabedian, A.The quality of care. How can it be assessed? JAMA 1988; 260:1743–1748.CrossRefGoogle ScholarPubMed
Doughty, J., Baker, G.A., Jacoby, A., Lavaud, V.Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy Epilepsy Behav. 2003; 4:710–716.CrossRefGoogle ScholarPubMed
Druss, B.G., Rosenheck, R.A., Stolar, M.Patient satisfaction and administrative measures as indicators of the quality of mental health care Psychiatr. Serv. 1999; 50:1053–1058.CrossRefGoogle ScholarPubMed
Falissard, B.Structurer des relations Masson, editor Mesurer la subjectivité en santé. Perpective méthodologique et statistique Paris: 2001. 131–141.Google Scholar
Gaite, L., Vazquez-Barquero, J., Arrizabalaga, A., Schene, A., Welcher, B., Thornicroft, G.et al.Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile—European Version: Epsilon study 8 Br. J. Psychiatry 2000; 177:s49–s54.CrossRefGoogle Scholar
Gonzales, R., Steiner, J.F., Maselli, J., Lum, A., Barrett, P.H. Jr.Impact of reducing antibiotic prescribing for acute bronchitis on patient satisfaction Eff. Clin. Pract. 2001; 4:105–111.Google ScholarPubMed
Haro, J.M., Edgell, E.T., Jones, P.B., Alonso, J., Gavart, S., Gregor, K.J.et al.The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment Acta Psychiatr. Scand. 2003; 107:222–232.CrossRefGoogle ScholarPubMed
Haro, J.M., Kamath, S.A., Ochoa, S., Novick, D., Rele, K., Fargas, A.et al.The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia Acta Psychiatr. Scand. Suppl 2003 16–23.CrossRefGoogle Scholar
Himmel, W., Lippert-Urbanke, E., Kochen, M.M.Are patients more satisfied when they receive a prescription? The effect of patient expectations in general practice Scand. J. Prim. Health Care 1997; 15:118–122.CrossRefGoogle ScholarPubMed
Hogan, T.P., Awad, A.G.Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures Psychol. Med. 1992; 22:347–352.CrossRefGoogle ScholarPubMed
Hogan, T.P., Awad, A.G., Eastwood, R.A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity Psychol. Med. 1983; 13:177–183.CrossRefGoogle ScholarPubMed
Holcomb, W.R., Parker, J.C., Leong, G.B., Thiele, J., Higdon, J.Customer satisfaction and self-reported treatment outcomes among psychiatric inpatients Psychiatr. Serv. 1998; 49:929–934.CrossRefGoogle ScholarPubMed
Kampman, O., Lehtinen, K., Lassila, V., Leinonen, E., Poutanen, O., Koivisto, A.Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire Schizophr. Res. 2000; 45:223–234.CrossRefGoogle ScholarPubMed
Keefe, R.S., Seidman, L.J., Christensen, B.K., Hamer, R.M., Sharma, T., Sitskoorn, M.M.et al.Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol Am. J. Psychiatry 2004; 161:985–995.CrossRefGoogle ScholarPubMed
Lambert, M.F., Wood, J.Incorporating patient preferences into randomized trials J. Clin. Epidemiol. 2000; 53:163–166.CrossRefGoogle ScholarPubMed
Lenert, L.A., Ziegler, J., Lee, T., Sommi, R., Mahmoud, R.Differences in health values among patients, family members, and providers for outcomes in schizophrenia Med. Care 2000; 38:1011–1021.CrossRefGoogle Scholar
Leucht, S., Wahlbeck, K., Hamann, J., Kissling, W.New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis Lancet 2003; 361:1581–1589.CrossRefGoogle ScholarPubMed
Loehlin, J.C., Mahwah, N.J.Latent variable models: an introduction to factor, path, and structural equation analysis L. Erlbaum Associates: 2004; 317.CrossRefGoogle Scholar
Longford, N.T.Selection bias and treatment heterogeneity in clinical trials Stat. Med. 1999; 18:1467–1474.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Malm, U., Lewander, T.Consumer satisfaction in schizophrenia. A 2-year randomized controlled study of two community-based treatment programs Nord. J. Psychiatry 55(Suppl 44)2001 91–96.Google ScholarPubMed
Naber, D.A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables Int. Clin. Psychopharmacol. 10(Suppl 3)1995 133–138.Google ScholarPubMed
Priebe, S., Gruyters, T.Patients' assessment of treatment predicting outcome Schizophr. Bull. 1995; 21:87–94.CrossRefGoogle ScholarPubMed
Priebe, S., Kaiser, W., Huxley, P.J., Roder-Wanner, U.U., Rudolf, H.Do different subjective evaluation criteria reflect distinct constructs? J. Nerv. Ment. Dis. 1998; 186:385–392.CrossRefGoogle ScholarPubMed
Prieto, L., Novick, D., Sacristan, J.A., Edgell, E.T., Alonso, J.A Rasch model analysis to test the cross-cultural validity of the EuroQoL-5D in the Schizophrenia Outpatient Health Outcomes Study Acta Psychiatr. Scand. Suppl 2003 24–29.CrossRefGoogle Scholar
Roghmann, K.J., Hengst, A., Zastowny, T.R.Satisfaction with medical care: its measurement and relation to utilization Med. Care 1979; 17:461–479.CrossRefGoogle Scholar
Rohland, B.M., Langbehn, D.R., Rohrer, J.E.Relationship between service effectiveness and satisfaction among persons receiving Medicaid mental health services Psychiatr. Serv. 2000; 51:248–250.CrossRefGoogle ScholarPubMed
Shapiro, E.Injudicious antibiotic use: an unforeseen consequence of the emphasis on patient satisfaction? Clin. Ther. 2002; 24:197–204.CrossRefGoogle ScholarPubMed
Sitzia, J., Wood, N.Patient satisfaction: a review of issues and concepts Soc. Sci. Med. 1997; 45:1829–1843.CrossRefGoogle ScholarPubMed
Thompson, K., Kulkarni, J., Sergejew, A.A.Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses Schizophr. Res. 2000; 42:241–247.CrossRefGoogle ScholarPubMed
Voruganti, L., Cortese, L., Owyeumi, L., Kotteda, V., Cernovsky, Z., Zirul, S.et al.Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study Schizophr. Res. 2002; 57:201–208.CrossRefGoogle ScholarPubMed
Voruganti, L., Cortese, L., Oyewumi, L., Cernovsky, Z., Zirul, S., Awad, A.Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life Schizophr. Res. 2000; 43:135–145.CrossRefGoogle ScholarPubMed
Ware, J.E. Jr., Snyder, M.K., Wright, W.R., Davies, A.R.Defining and measuring patient satisfaction with medical care Eval. Program Plann. 1983; 6:247–263.CrossRefGoogle ScholarPubMed
Weiden, P.J., Mackell, J.A., McDonnell, D.D.Obesity as a risk factor for antipsychotic noncompliance Schizophr. Res. 2004; 66:51–57.CrossRefGoogle ScholarPubMed
Williams, B.Patient satisfaction: a valid concept? Soc. Sci. Med. 1994; 38:509–516.CrossRefGoogle ScholarPubMed
Winefield, H.R., Murrell, T.G., Clifford, J.Process and outcomes in general practice consultations: problems in defining high quality care Soc. Sci. Med. 1995; 41:969–975.CrossRefGoogle ScholarPubMed
Witthaus, E., Stewart, J., Bradley, C.Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes Diabet. Med. 2001; 18:619–625.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.